Additionally, dysregulated Fn in CRC would drive adaptive immunity dysfunction, leading to immunotherapy resistance and resultant fast tumor progression via inherent disruption of group 3 innate lymphoid cells (ILC3s) [17]. The gene discussed is FN1; the disease is colorectal carcinoma.